These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21684816)

  • 21. Prostate brachytherapy post-implant dosimetry: a comparison between higher and lower source density.
    Thomas CW; Kruk A; McGahan CE; Spadinger I; Morris WJ
    Radiother Oncol; 2007 Apr; 83(1):18-24. PubMed ID: 17368844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of anatomy-based inverse planning with simulated annealing and graphical optimization for high-dose-rate prostate brachytherapy.
    Morton GC; Sankreacha R; Halina P; Loblaw A
    Brachytherapy; 2008; 7(1):12-6. PubMed ID: 18037356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of dosimetric and biologic effective dose parameters for prostate and urethra using 131 Cs and 125 I for prostate permanent implant brachytherapy.
    Sahgal A; Jabbari S; Chen J; Pickett B; Roach M; Weinberg V; Hsu IC; Pouliot J
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):247-54. PubMed ID: 18722275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adaptation of the CVT algorithm for catheter optimization in high dose rate brachytherapy.
    Poulin E; Fekete CA; Létourneau M; Fenster A; Pouliot J; Beaulieu L
    Med Phys; 2013 Nov; 40(11):111724. PubMed ID: 24320432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Needle migration and dosimetric impact in high-dose-rate brachytherapy for prostate cancer evaluated by repeated MRI.
    Buus S; Lizondo M; Hokland S; Rylander S; Pedersen EM; Tanderup K; Bentzen L
    Brachytherapy; 2018; 17(1):50-58. PubMed ID: 28935450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-time intraoperative evaluation of implant quality and dose correction during prostate brachytherapy consistently improves target coverage using a novel image fusion and optimization program.
    Zelefsky MJ; Cohen GN; Taggar AS; Kollmeier M; McBride S; Mageras G; Zaider M
    Pract Radiat Oncol; 2017; 7(5):319-324. PubMed ID: 28377139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.
    Mangili P; Stea L; Cattani F; Lappi S; Giglioli F; Calamia E; Ziglio F; Martinelli R; Longobardi B
    Radiother Oncol; 2004 Apr; 71(1):13-21. PubMed ID: 15066291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
    Nickers P; Thissen B; Jansen N; Deneufbourg JM
    Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Justification for inter-fraction correction of catheter movement in fractionated high dose-rate brachytherapy treatment of prostate cancer.
    Simnor T; Li S; Lowe G; Ostler P; Bryant L; Chapman C; Inchley D; Hoskin PJ
    Radiother Oncol; 2009 Nov; 93(2):253-8. PubMed ID: 19854524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs.
    Beaulieu L; Archambault L; Aubin S; Oral E; Taschereau R; Pouliot J
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1298-308. PubMed ID: 15001275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosimetric evaluation of high-dose-rate interstitial brachytherapy boost treatments for localized prostate cancer.
    Fröhlich G; Agoston P; Lövey J; Somogyi A; Fodor J; Polgár C; Major T
    Strahlenther Onkol; 2010 Jul; 186(7):388-95. PubMed ID: 20582396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of needle displacement in multifraction high-dose-rate prostate brachytherapy: A prospective volumetric analysis and technical considerations.
    Peddada AV; Blasi OC; White GA; Monroe AT; Jennings SB; Gibbs GL
    Pract Radiat Oncol; 2015; 5(4):228-37. PubMed ID: 25543199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Technical acquisition and dosimetric assessment of iodine-125 permanent brachytherapy in localized prostate cancer: our first series of 100 patients.
    Tanaka N; Asakawa I; Kondo H; Tanaka M; Fujimoto K; Hasegawa M; Konishi N; Hirao Y
    Int J Urol; 2009 Jan; 16(1):70-4. PubMed ID: 19120529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy?
    Potters L; Calugaru E; Jassal A; Presser J
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1014-9. PubMed ID: 16682144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.
    Krishnamurthy D; Weinberg V; Cunha JA; Hsu IC; Pouliot J
    Brachytherapy; 2011; 10(6):461-5. PubMed ID: 21397569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Placement of empty catheters for an HDR-emulating LDR prostate brachytherapy technique: comparison to standard intraoperative planning.
    Niedermayr TR; Nguyen PL; Murciano-Goroff YR; Kovtun KA; Neubauer Sugar E; Cail DW; O'Farrell DA; Hansen JL; Cormack RA; Buzurovic I; Wolfsberger LT; O'Leary MP; Steele GS; Devlin PM; Orio PF
    Brachytherapy; 2014; 13(4):375-9. PubMed ID: 24613569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer.
    Konishi K; Yoshioka Y; Isohashi F; Sumida I; Kawaguchi Y; Kotsuma T; Adachi K; Morimoto M; Fukuda S; Inoue T
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1003-7. PubMed ID: 19345517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward a dynamic real-time intraoperative permanent prostate brachytherapy methodology.
    Potters L; Calguaru E; Thornton KB; Jackson T; Huang D
    Brachytherapy; 2003; 2(3):172-80. PubMed ID: 15062140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraoperative ultrasound-based planning can effectively replace postoperative CT-based planning for high-dose-rate brachytherapy for prostate cancer.
    Batchelar DL; Chung HT; Loblaw A; Law N; Cisecki T; Morton GC
    Brachytherapy; 2016; 15(4):399-405. PubMed ID: 27180126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Technical improvement in permanent seed implantation: a two-stage brachytherapy system. Description and comparison with current technique.
    Grimm PD; Blasko JC; Sylvester JE; Heaney C; Gasparich J; Quackenbush J; Gottesman J; Downey J; Grier D; Roddy T; Nellans R; Sood N; Wahl D
    Brachytherapy; 2004; 3(1):34-40. PubMed ID: 15110312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.